Perrigo

76 results

Chief executive Joe Papa said it was an exceptional quarter for Perrigo.  Photograph: Brenda Fitzsimons

Strong growth at its nutritionals and store brand pharmaceutcials divisions drove revenue at Perrigo to record highs in the second quarter of its 2014(...)

Joe Papa: “It has never been my game to be active, outspoken; 
in fact I would say
Perrigo as a company 
that
has made tremendous progress 
as a company
and one of the things we said is to be low profile.” Photograph: Brenda Fitzsimons

The signs on the walls say Elan but Perrigo boss Joe Papa is very much in charge at what was, until recently, Ireland’s largest indigenous drug compan(...)

Mathew Martoma, a former SAC Capital Advisors fund manager exits federal court with his wife Rosemary Martoma,  in New York, today after being  found guilty in the most lucrative insider trading scheme ever. Photographer: Louis Lanzano/Bloomberg

Mathew Martoma, a former portfolio manager at billionaire Steven A. Cohen’s SAC Capital Advisors hedge fund, was found guilty tonight of engaging in w(...)

Perrigo’s €6.3 billion takeover of Elan (its Athlone plant is pictured) boosted the value of Irish M&A deals in 2013. Photographer: Dara MacDonaill/The Irish Times

FIONA REDDANThe value of Irish mergers and acquisitions (M&A) and equity capital market deals jumped by almost 40 per cent to €38.6 billion last y(...)

Perrigo chief executive Joe Papa.

The curtain came down last night on Elan’s existence as an independent company. The acquisition of the business founded in 1969 by Don Panoz to commer(...)

The Elan Corporation plant in Athlone, Co Westmeath. Photograph: John Cogill/Bloomberg News

The Commercial Court has approved the €6.27 billion acquisition of the Elan pharmaceutical group by US firm Perrigo. Mr Justice Peter Kelly made the r(...)

US generic drugmaker Perrigo is to pay $8.6 billion (€ 6.48 billion) for Elan. Photographer:John Cogill/Bloomberg News.

Shareholders in Elan overwhelmingly voted in favour of the proposed acquisition of the pharmaceutical group by the US company Perrigo this morning. At(...)

Elan put itself up for sale in June after rejecting a number of hostile bids from private equity firm Royal Pharma. Photograph:John Cogill/Bloomberg News.

Biotech company Elan reported a $13.8 million loss in the third quarter as costs associated with the proposed takeover by pharmaceuticals firm Perr(...)

US pharmaceutical firm Perrigo ’s agreement to acquire Dublin’s Elan for $8.6 billion is the biggest Irish deal of the year year so far. Photographer:John Cogill/Bloomberg News.

Irish deal volume and values fell in the first nine months of 2013, according to data from Experian.The total number of Irish M&A and equity capi(...)

Shareholders in biotech company Elan got an update on their opportunity to vote on Michigan-based pharmaceuticals group Perrigo’s proposed acquisition of the Irish company on November 18th in Dublin. Photographer: John Cogill/Bloomberg News

Investors worries that even a temporary US government shutdown could put a damper on an already weak economic recovery hung over global markets yester(...)

  • « First
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • Last »